Defilade Capital Management »

Henry Schein shares owned by Defilade Capital Management

Quarter-by-quarter ownership of Henry Schein (HSIC) shares owned by Defilade Capital Management from 13F filings

Historical chart of Defilade Capital Management investment in Henry Schein

Tip: Access up to 7 years of quarterly data

All positions including Henry Schein held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Henry Schein by Defilade Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $46M 624k 73.70

More positions owned by Defilade Capital Management

Zimmer Holdings (ZBH)
Henry Schein (HSIC)
Becton, Dickinson and (BDX)
Pfizer (PFE)
Dex (DXCM)
ICU Medical, Incorporated (ICUI)
Insmed Com Par $.01 (INSM)
Intuitive Surgical Com New (ISRG)
Revolution Medicines (RVMD)
Globus Med Cl A (GMED)
Neurocrine Biosciences (NBIX)
Denali Therapeutics (DNLI)
Ptc Therapeutics I (PTCT)
Olema Pharmaceuticals (OLMA)
Elanco Animal Health (ELAN)

View all positions for Defilade Capital Management

Top funds holding Henry Schein

Kohlberg Kravis Roberts & Co
Vanguard Group
BlackRock
Artisan Partners Limited Partnership
Vanguard Capital Management
Invesco
State Street Corporation
Vanguard Portfolio Management
FMR
American Century Companies
Palestra Capital Management
Southpoint Capital Advisors
Dimensional Fund Advisors
Geode Capital Management
Fiduciary Management

View all funds holding Henry Schein